| Ahn, Eun Hyun |
Johns Hopkins University
United States |
Engineered biomimetic collective cancer invasion models for screening chemotherapeutic agents |
5R01CA279948-02 |
|
Guillermo Marquez, Ph.D. |
| Borges, Chad R |
Arizona State University-Tempe Campus
United States |
Plate reader assays to forensically assess exposure of plasma and serum to thawed conditions |
5R21CA269091-03 |
RFA-CA-21-005 (R21 Clinical Trial Not Allowed) |
Indu Kohaar, Ph.D., M.Phil., M.Sc. |
| Simeone, Diane M |
University Of California, San Diego
United States |
Biomarker Validation in Pancreatic Cystic Neoplasms |
5U01CA282272-03 |
PAR-21-334 (U01 Clinical Trial Optional) |
Matthew Young, Ph.D. |
| Kumar, Nagi B. |
H. Lee Moffitt Cancer Ctr & Res Inst
United States |
Phase II Clinical trial of GTC in Men on Active Surveillance |
5R01CA235032-06 |
|
Howard L. Parnes, M.D. |
| Kelleher, Sarah |
Duke University
United States |
Randomized Controlled Trial of a Hybrid-Delivered Cognitive Behavioral Symptom Management and Activity Coaching Intervention for Stem Cell Transplant Patients |
5R01CA291888-02 |
|
Brennan Streck, Ph.D., RN, M.P.H. |
| Hoshida, Yujin |
Ut Southwestern Medical Center
United States |
Epigallocatechin gallate for prevention of lethal cirrhosis complications |
5R01CA282178-02 |
|
Asad Umar, D.V.M., Ph.D. |
| Lesch, Bluma J |
Yale University
United States |
Defining signatures of epigenetic sensitization to lung cancer in a mouse model |
5R21CA288677-02 |
|
Guillermo Marquez, Ph.D. |
| Kim, Michelle Kang |
Cleveland Clinic Lerner Com-Cwru
United States |
Assessing feasibility of gastric cancer screening in the US |
1R37CA300540-01 |
|
Claire Zhu, Ph.D. |
| Skubitz, Amy Patrice |
University Of Minnesota
United States |
A paradigm shift for ovarian cancer biomarkers: Utilizing routine Pap tests as liquid biopsies for the development of targeted mass spectrometry-based proteomic assays for early detection |
5R01CA262153-05 |
PA-20-185 (Parent R01 Clinical Trial Not Allowed) |
Christos Patriotis, Ph.D., M.Sc. |
| Gill, Brian John Andrew |
Columbia University Health Sciences
United States |
The Impact of Local and Reversible Change to GABAergic Inhibitory Signaling on Tumor-Induced Cortical Dysfunction in Glioma |
1R01NS140658-01A1 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
